Yves Courty - Concepedia

Author

Yves Courty

Université de Tours ORCID

Also Known As

Courty Yves, Courty, Y., Courty, Yves, Y Courty, Y. COURTY, Y. Courty, YVES COURTY, Yves Courty

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Université de Tours Inserm Centre d'Étude des Pathologies Respiratoires Centre Hospitalier Universitaire de Tours Centre National de la Recherche Scientifique

About

Yves Courty is an author at Université de Tours specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	22	728
2	Natural Sciences	4	4	100
3	Public Health	3	3	88
4	Allergy	3	3	79
5	Biochemistry	1	1	13

Yves Courty

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
A comprehensive nomenclature for serine proteases with homology to tissue kallikreins Åke Lundwall, Vimla Band, Michael Blaber, Biological Chemistry	2006	142
The Airways, a Novel Route for Delivering Monoclonal Antibodies to Treat Lung Tumors A. Maillet, Laurent Guilleminault, Étienne Lemarié, Pharmaceutical Research AsthmaTumor ImmunologyDelivering Monoclonal AntibodiesImmunologyNovel Route	2011	72
Rat Seminal Vesicle FAD-dependent Sulfhydryl Oxidase Béatrice Benayoun, Annick Esnard-Fève, Sandrine Castella, Journal of Biological Chemistry	2001	66
Kallikrein-related Peptidase 12 Hydrolyzes Matricellular Proteins of the CCN Family and Modifies Interactions of CCN1 and CCN5 with Growth Factors Audrey Guillon‐Munos, Noémie Michel, Chistopher R. Smith, Journal of Biological Chemistry	2011	61
Alternative Splicing Variant of Kallikrein-Related Peptidase 8 as an Independent Predictor of Unfavorable Prognosis in Lung Cancer Chris Planque, Yun‐Hee Choi, Serge Guyétant, Clinical Chemistry	2010	61
KLK5 and KLK7, two members of the human tissue kallikrein family, are differentially expressed in lung cancer Chris Planque, M. De Monte, Serge Guyétant, Biochemical and Biophysical Research Communications Oncogenic AgentMedicineHuman TissuePathologyCancer Genomics	2005	60
Aerodynamical, Immunological and Pharmacological Properties of the Anticancer Antibody Cetuximab Following Nebulization A. Maillet, Nicolas Congy‐Jolivet, Sandrine Le Guellec, Pharmaceutical Research MedicineImmunologyTumor ImmunityTherapeutic VaccineAntibody Screening	2007	58
Molecular cloning and expression of an alternative hKLK3 transcript coding for a variant protein of prostate-specific antigen. N Heuzé, Sophie Olayat, N Gutman, PubMed Urology2.1-Kb Hklk3 MrnaProtein ExpressionMedicineGenetics	1999	56
The oncomiR miR-197 is a novel prognostic indicator for non-small cell lung cancer patients Konstantinos Mavridis, Fabien Gueugnon, A Petit, British Journal of Cancer	2015	54
Downregulation of the neonatal Fc receptor expression in non-small cell lung cancer tissue is associated with a poor prognosis Emilie Dalloneau, Nadine Baroukh, Konstantinos Mavridis, Oncotarget	2016	48

Page 1